Aliskiren combined with losartan in diabetes and nephropathy.
Lindner
Thomas
T
D000577:Amides / Q000191:economics / Q000627:therapeutic use*; D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005650:Fumarates / Q000191:economics / Q000627:therapeutic use*; D006801:Humans; D019808:Losartan / Q000627:therapeutic use*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D011507:Proteinuria / Q000188:drug therapy*; D013148:Spironolactone / Q000627:therapeutic use; D000092502:Renin Inhibitors
D000577:Amides; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D005650:Fumarates; D019808:Losartan; D000451:Mineralocorticoid Receptor Antagonists; D013148:Spironolactone; D000092502:Renin Inhibitors; C446481:aliskiren